Skip to content
  1. 2023
  2. 2022
  3. 2021
  4. 2020
  5. 2019
  6. 2018

November 18, 2022

Neobiomics AB and ExCEEd Orphan s.r.o. announce an extended partnership for ProPrems® in Estonia, Latvia and Lithuania

Stockholm, Sweden, 17 Nov 2022 – Neobiomics AB and ExCEEd Orphan s.r.o. have …

November 1, 2022

ExCEEd Orphan announces new members of the team in several countries of the CEE region

ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in …

August 1, 2022

Rafa Laboratories to acquire a significant stake in ExCEEd Orphan and expand its international capabilities in medicines addressing rare diseases

Jerusalem, Israel and Prague, Czech Republic, August 1st, 2022. Rafa Laboratories LTD. (“Rafa”) …

July 15, 2022

ExCEEd Orphan announces new member of the EO Management team

ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in …

July 13, 2022

ExCEEd Orphan announces partnership with Amryt to exclusively distribute Filsuvez® in Central and Eastern Europe (CEE)

Under the terms of the agreement, ExCEEd Orphan will have exclusive rights to …

May 9, 2022

ExCEEd Orphan announces partnership with SERB to exclusively distribute Voraxaze® and DigiFab® in Central and Eastern Europe (CEE)

Under the terms of the agreement, ExCEEd Orphan will have exclusive rights to …

May 4, 2022

ExCEEd Orphan announces opening of the third non-EU affiliate in Albania

The ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions …

February 1, 2022

First sales of ProPrems in the CEE region

„ExCEEd Orphan and Neobiomics are happy to announce the first sales of ProPrems® …

February 1, 2022

ExCEEd Orphan announces new members of the team in Adriatic Region

ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in …